Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Beltran Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Job Opportunities
Videos
Affiliations
Research
Lab Team
News
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Affiliations
Research
Lab Team
News
Publications
Home
Publications
Publications
Found 6 results
Author
Title
Type
Year
Filters:
Author
is
Xue, Hui
[Clear All Filters]
2017
Wilkes DC
,
Sailer V
,
Xue H
,
Cheng H
,
Collins CC
,
Gleave M
,
Wang Y
,
Demichelis F
,
Beltran H
,
Rubin MA
et al.
. 2017.
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.
.
Cold Spring Harb Mol Case Stud. 3(5)
Li Y
,
Donmez N
,
Sahinalp C
,
Xie N
,
Wang Y
,
Xue H
,
Mo F
,
Beltran H
,
Gleave M
,
Wang Y
et al.
. 2017.
SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition.
.
Eur Urol. 71(1):68-78.
2015
Akamatsu S
,
Wyatt AW
,
Lin D
,
Lysakowski S
,
Zhang F
,
Kim S
,
Tse C
,
Wang K
,
Mo F
,
Haegert A
et al.
. 2015.
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
.
Cell Rep. 12(6):922-36.
Beltran H
,
Eng K
,
Mosquera JMiguel
,
Sigaras A
,
Romanel A
,
Rennert H
,
Kossai M
,
Pauli C
,
Faltas B
,
Fontugne J
et al.
. 2015.
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
.
JAMA Oncol. 1(4):466-74.
2014
Lin D
,
Wyatt AW
,
Xue H
,
Wang Y
,
Dong X
,
Haegert A
,
Wu R
,
Brahmbhatt S
,
Mo F
,
Jong L
et al.
. 2014.
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.
.
Cancer Res. 74(4):1272-83.
2012
Collins CC
,
Volik SV
,
Lapuk AV
,
Wang Y
,
Gout PW
,
Wu C
,
Xue H
,
Cheng H
,
Haegert A
,
Bell RH
et al.
. 2012.
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
.
Mol Cancer Ther. 11(3):775-83.